Meghan M. is a Senior Principal Scientist at Eli Lilly and Company, with a strong research background spanning eight years across various organizations, including Morphic Therapeutic and Addgene. They have held roles such as Senior Research Associate and Research Associate II, contributing significantly to the field of biochemistry and chemical biology. Meghan received a Master of Science in Biochemistry from the University of Connecticut and is currently pursuing a Ph.D. in Chemical Biology at Northeastern University. Their work has involved predicting cancer patient responses to therapies and co-authoring research grants.
This person is not in the org chart
This person is not in any teams
This person is not in any offices